Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

New communication concept highlights BillerudKorsnäs as change ambassador

Change often begins with a question. This fact forms the basis of BillerudKorsnäs’ new communication concept “What if?” – with the ambition to inspire more to challenge conventional packaging for a sustainable future.BillerudKorsnäs’ mission, to challenge conventional packaging for a sustainable future, is based on the fact that innovative and sustainable packaging solutions have an important role to play in delivering solutions to some of the global challenges that we all face today. Through the communication concept “What If?”, classic product positioning is replaced with open questions

Conversion of shares

According to Husqvarna AB´s articles of association, owners of Class A shares have the right to have such shares converted to Class B shares. Conversion reduces the total number of votes in Husqvarna AB. When such a conversion has occurred, the company is obligated by the Act on Trading in Financial Instruments to disclose any such change. In January 2018, at the request of shareholders, 800 Class A shares were converted to Class B shares. The total number of votes thereafter amounts to 158,895,358.7. The total number of registered shares in the company amounts to 576,343,778 shares

Ziccum achieves proof-of-concept in new antibody study

80% of human immunoglobulin antibodies, used to treat a wide range of diseases, are formulated as liquids, which can mean they are fragile, unstable and costly to transport. New results show that Ziccum AB’s spray drying instrument LaminarPace can produce a stable dry powder form of immunoglobulin antibodies—with confirmed activity. ‘This is an important milestone,’ says Ziccum CEO Göran Conradson.The tests, carried out in ISAB’s labs, dried three samples of liquid Immunoglobulin G (IgG) at room temperature, achieving high yields of powder. 25.5 mg of dry powder IgG was generated from a

Pelican chooses Zeeland Family as its agile marketing partner

The leading self-storage provider Pelican Self Storage and Zeeland Family begin an all-encompassing marketing cooperation. By utilizing agile methods from the get-go, the aim is to transform the clutter-filled spaces in Finland to better use. Pelican Self Storage will hand over the development and execution of its operative marketing and marketing plan to Zeeland Family. The cooperation contains both strategic planning, as well as media and digital solutions. “The self-storage solution provided by Pelican has proven to be an excellent concept, yet one that has stayed relatively

Direct sales create results

In January 2017, a dedicated sales representative was employed to handle the domestic Nordic market. The transition to direct sales in the Nordic region has after a startup period led to a clear increase in sales on the Nordic market, comprising of accessories and several HoloMonitor units. Among the customers are University of Bergen, University of Gothenburg and Lund University. “Through the transition to direct sales, we see that dedicated sales staff lead to increasing sales. We thus look forward to rising revenues, as marketing and sales operations continue to expand both

Diaverum acquires two clinics in Brazil, and enters the largest country in Latin America

Diaverum creates a strong presence from the start through the acquisition of the two clinics in Ameng and Clinese. 900 patients will be treated in the clinics and the number is expected to grow.SAO PAULO/GOTHENBURG, (January 31st, 2018) - Diaverum, one of the leading renal care providers worldwide, announce the acquisition of two dialysis treatment centres in the States of Sao Paulo and Sergipe, respectively. With these two acquisitions Diaverum will treat 900 dialysis patients on the Brazilian market and aims to expand further during 2018. Both Ameneg and Clinese have impressive numbers

Dome Energy AB gives reserve update; Proven reserves value up 130%

Dome Energy AB.  (herein after “Dome” and/or “the Company”) announces a large increase in its Oil and Gas reserves. A third-party engineering company has in a report valued Domes proven reserves at $124mm, which is up from $53mm at the end of 2016, with an addition of high quality probable reserves valued at $16mm. The reserve volumes have increased with 70% during the same period, from 4.5 MBOE to 7.6 MBOE. Paul Mørch, CEO: “We are pleased to see that we have been able to achieve this large increase in reserves and value. A large portion of this value is

NextCell Pharma changes ticker to NXTCL

NextCell Pharma AB ("NextCell") announces that it will change its ticker on Aktietorget to NXTCL.Since its listing on Aktietorget (2017-07-13), NextCell has been traded using the ticker NEXTCL. Management hasdecided to change the ticker to NXTCL. The new abbreviation might also be used in general market communicationsand company branding. The new ticker will become effective as per 2018-02-07, the company name and ISIN-code (SE0009723125) willremain the same. This information is the information that NextCell Pharma AB is required to disclose under the EU Market AbuseRegulation.

Financial Statements Release 2017: Excellent finish to the record-strong year 2017

UPM-Kymmene Corporation      Financial Statements Release         31 January 2018 at 09:45 EET Financial Statements Release 2017:Excellent finish to the record-strong year 2017 Q4 2017 highlights · Comparable EBIT increased by 29% to EUR 366 million (283 million in Q4 2016). · Sales prices and delivery growth boosted earnings, outstripping the impact of higher input costs and unfavourable currencies. · Strong operating cash flow at EUR 407 million (405 million). · Net debt decreased to EUR 174 million (1,131 million). · UPM and the Government of Uruguay

The rights issue of Oncology Venture is oversubscribed

Hørsholm, Denmark, January 31st, 2018 – Oncology Venture Sweden AB (”Oncology Venture”) today announces that the company’s rights issue of approximately SEK 44.7 million in order to finance planned clinical trials with existing drug candidates and establish a financial buffer, has been oversubscribed. The rights issue was subscribed to approximately SEK 59.6 million, responding to a subscription rate of approximately 133 percent. Through the rights issue a total of 2.745.143 shares are issued and Oncology Venture are provided approximately SEK 44.7 million before issuing costs. The issuing

Eyeonid Group AB secures external financing of up to SEK 100 million and issues free warrants to its shareholders

Eyeonid Group AB ("Eyeonid Group") has signed an agreement relating to an investment of up to SEK 100 million. The capital will be used for expanding our sales & marketing activities in line with the strategy of reaching out to a global market with Eyeonid Group’s products.The transaction is carried out through a private placement of convertible notes with warrants attached in several tranches spread over 36 months (each, a “Tranche”). Eyeonid Group will receive SEK 20 million through the first Tranche. Existing shareholders will receive free warrants to protect them against dilution.- "

Beijer Ref Q4 2017

Strongest-ever fourth quarterNet sales for the fourth quarter of 2017 increased by 9 per cent compared with the corresponding period in the previous year and amounted to SEK 2,401M (2 199). Operating profit for the fourth quarter of 2017 amounted to SEK 179M (145). It is an improvement of 24 per cent compared with the same period last year. Profit for the quarter amounted to SEK 146M (100). Profit per share amounted to SEK 3.39 (2.29). The acquisition of Tecsa (Pty) Ltd has now been approved by the competition authority in South Africa and the planned takeover date is expected

C-RAD AB – Consolidated Year-End report January-December 2017

POSITIVE RESULT FOR THE FOURTH QUARTER 2017 Key events in the period October - December 2017 FOURTH QUARTER 2017                                                    · Order intake: 47.5 (41.9) MSEK, +13%. · Revenues: 42.0 (27.3) MSEK, +54%. · Operating profit: 1.1 (-4.4) MSEK. · Net results after tax: 0.8 (-4.6) · Result per share: 0.03 (-0.16) SEK. Comments from Tim Thurn, CEO: We delivered another solid quarter and a strong finish to the year with significant growth in revenue, an operating profit and a significant increase in order intake compared to the same

Experienced finance professional becomes new CFO of Soluno

Jane Carlgren took over as CFO of Soluno BC on 1 January 2018. She has more than 20 years of experience in the fields of economics and finance from her previous roles in large and medium-sized companies. “Given her strong background and expertise, Jane will be a great asset to Soluno, both strategically and in day-to-day operations,” says Mattias Ohde, CEO of Soluno BC.Jane Carlgren began her career in the finance industry with Kinnevik during its tough years in the 90s. She later moved to Åhléns and then to Telefos, where she gained equivalent experience in two other industries. In order

Afound – an innovative off-price marketplace – launches in 2018

Afound will be a marketplace, a “style- and deal-hunting paradise” selling discounted fashion and lifestyle products, with both external and the H&M group’s own brands, offering a wide range of well-known, popular brands for both women and men. Afound will present a carefully selected, season-less range from Swedish and international brands in a variety of price segments both online and in physical stores. Afound will also launch unique, limited product releases from a range of brands, all at attractive prices. “We see big potential for Afound and are looking forward to introducing the

President and CEO Jonas Samuelson’s comments on the results for the fourth quarter 2017

Operating margin target achieved for 2017Electrolux reached an operating margin of 6.1% during 2017, an improvement of close to 20%. This was an important step on the journey towards profitable growth, supported by a strong focus on product portfolio management and cost efficiencies. The year ended with a strong fourth quarter delivering an organic growth of 4% and a margin of 6.1%. In 2017, we had a consistent focus on driving sustainable profitability through portfolio management and cost efficiencies. As a result, we improved earnings across all our business areas and generated a

New number of votes in Bonava AB due to conversion

The number of shares and votes in Bonava AB has changed due to conversions of a total of 10,525 shares of series A to a total of 10,525 shares of series B.According to Bonava’s articles of association, owner of a share of series A has the right to request that such share is converted to a share of series B. In December, 10,525 shares of series A shares were converted to 10,525 shares of series B at the request of shareholders. Following the conversions, there were, as of January 31, the last trading day of the month, a total of 108,435,822 registered shares in Bonava AB. Of these 13,158,980

Invitation to presentation of Bactiguard’s year end report for 2017 on February 6, 2018

Bactiguard Holding AB (publ) publishes the year end report for 2017 on Tuesday, February 6, 2018 at 8:00 CET.In connection with this, a conference call for investors, analysts and media will be held at 10:00 CET on February 6. CEO Christian Kinch and CFO Cecilia Edström will present the interim report and answer questions. The year end report and a presentation for the conference call will be available at Bactiguard’s website www.bactiguard.com from 8:00 CET the same day.     To participate in the conference call, please dial +46 8 566 426 99 For further information, please contact:

Electrolux Consolidated Results 2017

Highlights of the fourth quarter of 2017· Net sales increased to SEK 32,366m (32,144). · Organic sales growth was 4.0%, contribution from acquisitions and divestments was 1.4% while currency translation had a negative impact of 4.7%.  · Operating income increased to SEK 1,969m (1,616), corresponding to a margin of 6.1% (5.0). · Four business areas achieved an operating margin of more than 8%. · Operating cash flow after investments amounted to SEK 2.1bn (2.6). · Income for the period increased to SEK 1,930m (1,272), and earnings per share was SEK 6.72 (4.43). · The

ENQUEST PLC ANNOUNCES AGREEMENT WITH BP ON THISTLE DECOMMISSIONING

31 January 2018  Following the completion of the acquisition of an initial 25% interest in the Magnus oil field on 1 December 2017, EnQuest PLC ('EnQuest') is pleased to announce it has agreed with BP to undertake the management of the physical decommissioning activities for Thistle and Deveron. Under the terms of this agreement with BP: · EnQuest will receive $30 million in cash in exchange for undertaking the management of the physical decommissioning and making payments by reference to 3.7% of the gross decommissioning costs of the Thistle and Deveron fields when spend

Proposal of the Shareholders' Nomination Board on the composition and remuneration of the Board of Directors of Finnair Plc

The Shareholders' Nomination Board proposes to Finnair Plc's Annual General Meeting (AGM) to be held on 20 March 2018 that the number of members of the Board of Directors would be confirmed as eight. Proposal on the composition of the Board of Directors The Shareholders' Nomination Board proposes that Colm Barrington, Mengmeng Du, Maija-Liisa Friman, Jouko Karvinen, Jonas Mårtensson and Jaana Tuominen be re-elected as members of the Board of Directors, and that Montie Brewer and Henrik Kjellberg be elected as new members to the Board of Directors. All candidates have given their

Increase of number of votes in Hansa Medical AB (publ)

The number of votes in Hansa Medical AB (publ) has changed as a result of conversion of in total 70,739 C shares into ordinary shares carried out in January under Hansa Medical’s long-term incentive programme.As of January 31, 2018, the total number of registered and outstanding shares of Hansa Medical amounts to 38,208,386 of which 37,878,125 ordinary shares, together carrying 37,878,125 votes, and 330,261 C shares, together carrying 33,026.1 votes. The total number of votes in Hansa Medical is 37,911,151.1.   This information is information that Hansa Medical AB (publ) is obliged to

Pihlajalinna acquires Kymijoen Työterveys

Pihlajalinna Plc     Press release       31 January 2018 at 9:00 a.m. Pihlajalinna acquires Kymijoen Työterveys Pihlajalinna acquires the entire share capital of Kymijoen Työterveys Oy from the City of Kotka. The transaction was completed on 30 January 2018. The four clinics of Kymijoen Työterveys became part of Pihlajalinna’s chain of private clinics. With the acquisition of Kymijoen Työterveys, Pihlajalinna expands its operations in the Kymenlaakso, Kotka and Kouvola areas, and realises its national expansion plan before the implementation of the healthcare and social welfare

RNB issues senior secured notes of SEK 400 M

RNB Retail and Brands AB (publ) (the “Company”) issues senior secured notes of SEK 400 M with a maturity of 3 years on the Nordic bond market.The notes have a floating interest rate of Stibor 3m + 600 basis points with a final maturity date on 2 February 2021. Notes may be issued up to a total maximum amount of SEK 600 M. The initial notes issue amounts to SEK 400 M. The Company intends to apply for listing of the notes on Nasdaq Stockholm. The proceeds from the contemplated notes issue will be used for refinancing of outstanding financial indebtedness and general corporate purposes. “

There are no items matching the current filter
There are no more items matching the current filter
Back to top